Table 2 BMI and current NSAID/aspirin use stratified by HRT users and non-users1 in 1991–1994 and 1997–2001 [17, 18]
|  | 1991–1994 | 1997–2001 |  | ||
|---|---|---|---|---|---|
| Â | HRT Yes (36% of population) N (%) | HRT No (648% of population) N (%) | HRT Yes (51% of population) N (%) | HRT No (49% of population) N (%) | P value2 |
BMI (kg/m2) | Â | Â | Â | Â | Â |
≤ 23 | 49 (25.0) | 80 (22.4) | 41 (21.9) | 32 (17.2) | <0.01 |
24–25 | 36 (18.4) | 59 (16.5) | 28 (15.0) | 30 (16.1) |  |
26–29 | 56 (28.6) | 98 (27.5) | 64 (34.2) | 55 (29.6) |  |
≥ 30 | 55 (28.1) | 120 (33.6) | 54 (28.9) | 69 (37.1) |  |
NSAIDs/aspirin | Â | Â | Â | Â | |
Yes | 91 (45.3) | 137 (37.7) | 93 (48.2) | 85 (45.7) | <0.01 |
No | 110 (54.7) | 226 (62.3) | 100 (51.8) | 101 (54.3) | Â |